Literature DB >> 10395049

Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

M G Schlumberger1, J C Desenclos, G Papaevangelou, S C Richardson, R Ancelle-Park.   

Abstract

The objective of the study was to analyse the effect of knowledge of HIV serostatus on behaviours preventing the acquisition or transmission of HIV among European IDU, and to compare results with a previous similar study conducted 3 years before. Data were gathered in 1992-1993 during a retrospective multicentre cross-sectional study of IDU recruited in 11 European countries, in specialized centers and on the street. We compared, between groups with different HIV serological status (IDU who knew well before their HIV-positive serological status, IDU who knew their HIV-negative serostatus and IDU who did not know before their serological status), the respective proportions of IDU who reported that, during the six months prior to interview, (1) always used condoms, (2) never gave their used injecting equipment to other IDU, (3) always injected drugs safely. We only included IDU who had known their serological status for at least six months prior to interview. Results were compared to the similar survey conducted in 1990. From 2171 IDU recruited, data of 1334 IDU were included in the analysis. Compared with IDU who did not know their HIV serostatus, only IDU knowing their HIV-positive serostatus used condoms significantly more often (37% compared to 15%, rate ratio (RR): 2.4; 95% confidence interval (CI): 1.8-2.3) and never gave their used injecting equipment to other IDU (69% compared to 53%, RR: 1.3; 95% CI: 1.2-1.4). In comparison with the 1990 study, only condom use significantly improved and only for IDU who knew their HIV-negative serostatus (13% compared to 9%, RR: 1.6; 95% CI: 1.1-2.3). This study confirms among European IDU the relation between knowing own HIV serological status to preventive behaviours. However, there were only minor improvements between 1990 and 1992-1993, indicating that prevention of HIV transmission among IDU must be reinforced.

Entities:  

Mesh:

Year:  1999        PMID: 10395049     DOI: 10.1023/a:1007578402083

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  41 in total

1.  Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies.

Authors:  R Power; R Hartnoll; E Daviaud
Journal:  Br J Addict       Date:  1988-06

2.  Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-08-14       Impact factor: 17.586

3.  Factors associated with HIV seropositivity in European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.

Authors:  C Richardson; R Ancelle-Park; G Papaevangelou
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

4.  Knowledge, attitudes and beliefs of European injecting drug users concerning preventive measures for HIV.

Authors:  S C Richardson; G Papaevangelou; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

Review 5.  How effective are risk-reduction interventions targeting injecting drug users?

Authors:  R E Booth; J K Watters
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

Review 6.  Evidence for the effects of HIV antibody counseling and testing on risk behaviors.

Authors:  D L Higgins; C Galavotti; K R O'Reilly; D J Schnell; M Moore; D L Rugg; R Johnson
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

7.  Are HIV-infected injection drug users taking HIV tests?

Authors:  J Reardon; N Warren; R Keilch; D Jenssen; F Wise; W Brunner
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

8.  Influence of human immunodeficiency virus antibody testing on sexual behaviour in a "high-risk" population from a "low-risk" city.

Authors:  I H Frazer; M McCamish; I Hay; P North
Journal:  Med J Aust       Date:  1988-10-03       Impact factor: 7.738

9.  Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men.

Authors:  J McCusker; A M Stoddard; K H Mayer; J Zapka; C Morrison; S P Saltzman
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

Review 10.  Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

Authors:  P W Brickner; R A Torres; M Barnes; R G Newman; D C Des Jarlais; D P Whalen; D E Rogers
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

View more
  18 in total

1.  Unprotected sex in heterosexual partnerships of injecting drug users in st. Petersburg, Russia.

Authors:  V Anna Gyarmathy; Nan Li; Karin E Tobin; Irving F Hoffman; Nikolai Sokolov; Julia Levchenko; Julia Batluk; Andrei A Kozlov; Andrei P Kozlov; Carl A Latkin
Journal:  AIDS Behav       Date:  2011-01

2.  Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.

Authors:  Laura B Moyer; Kimberley C Brouwer; Stephanie K Brodine; Rebeca Ramos; Remedios Lozada; Michelle Firestone Cruz; Carlos Magis-Rodriguez; Steffanie A Strathdee
Journal:  Drug Alcohol Rev       Date:  2008-01

3.  HIV and HCV discordant injecting partners and their association to drug equipment sharing.

Authors:  Prithwish De; Joseph Cox; Jean-Francois Boivin; Robert W Platt; Ann M Jolly; Paul E Alexander
Journal:  Scand J Infect Dis       Date:  2009

4.  HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation.

Authors:  Lauretta E Grau; Edward White; Linda M Niccolai; Olga V Toussova; Sergei V Verevochkin; Andrei P Kozlov; Robert Heimer
Journal:  AIDS Behav       Date:  2011-01

5.  Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors.

Authors:  V Anna Gyarmathy; Alan Neaigus; Eszter Ujhelyi; Tímea Szabó; József Rácz
Journal:  Drug Alcohol Depend       Date:  2006-04       Impact factor: 4.492

6.  Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.

Authors:  V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin
Journal:  Scand J Infect Dis       Date:  2010-09-15

7.  The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Mary M Mitchell; Eszter Ujhelyi
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

8.  Injecting equipment sharing in Russian drug injecting dyads.

Authors:  V Anna Gyarmathy; Nan Li; Karin E Tobin; Irving F Hoffman; Nikolai Sokolov; Julia Levchenko; Julia Batluk; Andrei A Kozlov; Andrei P Kozlov; Carl A Latkin
Journal:  AIDS Behav       Date:  2009-02-13

9.  Correlates of unsafe equipment sharing among injecting drug users in St. Petersburg, Russia.

Authors:  V Anna Gyarmathy; Nan Li; Karin E Tobin; Irving F Hoffman; Nikolai Sokolov; Julia Levchenko; Julia Batluk; Andrei A Kozlov; Andrei P Kozlov; Carl A Latkin
Journal:  Eur Addict Res       Date:  2009-06-05       Impact factor: 3.015

10.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.